Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.
about
Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.Delayed cardiomyopathy in dystrophin deficient mdx mice relies on intrinsic glutathione resource.Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease.Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo.Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts.Vascular-targeted therapies for Duchenne muscular dystrophyNovel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agentsPrimary myopathies and the heart.Fetuin A stabilizes m-calpain and facilitates plasma membrane repair.Severe dystrophic cardiomyopathy caused by the enteroviral protease 2A-mediated C-terminal dystrophin cleavage fragment.Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
P2860
Q33871052-04F8A9B6-9A39-411C-9848-9AAD7B663DC6Q33901556-FB97A990-A9BB-4445-8CD5-F60E446ADED3Q34086953-6BAFB49D-AC82-477F-B5FF-4E6D74EFD84BQ34508301-098D496D-A63B-4457-BED3-94890D8DAEC2Q36270889-1ECE7D04-0277-4CBB-90B0-807778C1BBF2Q36309327-AD294D6B-D206-4512-815B-9F6A30FD18B2Q36835180-DAE57D2A-A165-4E8C-9C79-2B6CB8833F0BQ36925191-9208EE0E-B0B5-4949-85CA-65DC3D410708Q37084285-E69C6A58-BD76-4227-8598-ADB173A7AF46Q40066666-1AF90B96-CC20-4835-AE04-C741E7F826F0Q40774423-50BAE1B3-9FD8-4797-8C0B-5364E83F8F6CQ41151043-74959424-28E9-4CF7-BB90-245BCBF22C37
P2860
Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cardiomyopathy of Duchenne mus ...... as a new therapeutic approach.
@ast
Cardiomyopathy of Duchenne mus ...... as a new therapeutic approach.
@en
type
label
Cardiomyopathy of Duchenne mus ...... as a new therapeutic approach.
@ast
Cardiomyopathy of Duchenne mus ...... as a new therapeutic approach.
@en
prefLabel
Cardiomyopathy of Duchenne mus ...... as a new therapeutic approach.
@ast
Cardiomyopathy of Duchenne mus ...... as a new therapeutic approach.
@en
P2093
P2860
P356
P1476
Cardiomyopathy of Duchenne mus ...... as a new therapeutic approach.
@en
P2093
DeWayne Townsend
Joseph Metzger
Soichiro Yasuda
P2860
P304
P356
10.1586/14779072.5.1.99
P577
2007-01-01T00:00:00Z